| SDS | TSLZ | SDS / TSLZ | |
| Gain YTD | -27.263 | -74.940 | 36% |
| Net Assets | 364M | 66.2M | 550% |
| Total Expense Ratio | 0.91 | 1.05 | 87% |
| Turnover | N/A | 0.00 | - |
| Yield | 7.17 | 7.68 | 93% |
| Fund Existence | 19 years | 2 years | - |
| SDS | TSLZ | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | N/A |
| Stochastic ODDS (%) | 2 days ago 84% | 2 days ago 89% |
| Momentum ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 88% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Advances ODDS (%) | 17 days ago 84% | 14 days ago 89% |
| Declines ODDS (%) | 2 days ago 90% | 7 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| IVGSX | 20.38 | 0.21 | +1.04% |
| VY® Invesco Growth and Income S | |||
| PHLQX | 53.03 | 0.52 | +0.99% |
| PGIM Jennison Health Sciences R6 | |||
| SUICX | 66.30 | 0.36 | +0.55% |
| DWS CROCI International C | |||
| PIEJX | 33.27 | 0.01 | +0.03% |
| Principal Glb Emerging Markets J | |||
| EEMRX | 9.99 | -0.02 | -0.20% |
| MFS Emerging Markets Equity Research C | |||